Page 6 - ஆராய்ச்சி இணைந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி இணைந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி இணைந்து Today - Breaking & Trending Today

Funding Success - World Class Research Project Grants


Funding Success – World Class Research Project Grants
Professor of Nursing at UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA), Professor Lynn Chenoweth, has been awarded $600,000 as one of five World Class Research Project Grants by the Dementia Centre for Research Collaboration (DCRC).
Her project will address the fact that hospital care of people living with dementia is complicated and challenges staff to meet the needs of each individual.
Professor Chenoweth, who is also Adjunct Professor in the School of Nursing, University of Notre Dame Australia and School of Nursing, Macau, China, says that “people living with dementia can have particularly difficult experiences including agitation, delirium and falls, in busy and unfamiliar hospital environments. ....

Lynn Chenoweth , Kaarin Anstey , Elizabeth Beattie , Henry Brodaty , University Of Notre Dame Australia , World Class Research Project Grants Funding Success , Dementia Centre For Research Collaboration , Sydney Centre For Healthy Brain Ageing Che , World Class Research Project , School Of Nursing , Funding Success , Class Research Project Grants , Healthy Brain Ageing , Professor Lynn Chenoweth , World Class Research Project Grants , Dementia Centre , Research Collaboration , Adjunct Professor , Notre Dame Australia , Professors Kaarin Anstey , லின் செனோவெத் , எலிசபெத் பீட்டி , பல்கலைக்கழகம் ஆஃப் நோட்ரே டேம் ஆஸ்திரேலியா , முதுமை மையம் க்கு ஆராய்ச்சி இணைந்து , சிட்னி மையம் க்கு ஆரோக்கியமான மூளை முதுமைப்படுதல் சே , பள்ளி ஆஃப் நர்சிங் ,

Austar Lifesciences : 2020 Annual Report


Dear Shareholders,
On behalf of the board ( Board ) of directors ( Directors ) of Austar Lifesciences Limited ( Company ), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the Group or AUSTAR ) for the year ended 31 December 2020 ( Year ).
The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China s pandemic conditions had become far stable and under extraordinary control. Under such conditions, the Group has been reacting, responding and acting during such extraordinary moments. Our colleagues could never have believed they were able to deliver our critical utilities and bioprocess systems to our COVID-19 vaccine manufacturer clients within 3 months from order to completion of installation and commissioning with ....

United States , Hong Kong , United Kingdom , University Of Adelaide , South Australia , West Yorkshire , United Kingdom General , New Territories , Hong Kong General , Wang Wei , Cayman Islands , United Group , Western Australia , Cheung Chau , Grand Cayman , University Of Hong Kong , Ji Lingling , E Pharma Gmb , Tang Xiangdi , Pharma Leantec , Kwok Keung , Austar Biosciences Gmb , Chiu Hoi Shan , S Tec Gmb , Verpackungstechnik Verwaltungsgesellschaft , S Tec Gmbhs ,

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy


Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy
LUND, Sweden, April 15, 2021 /PRNewswire/
Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator s proprietary patient specific immunotherapy Neo-X-Prime by incorporating MacroGenics proprietary DART
and TRIDENT
multi-specific platforms against two undisclosed targets.
Under the joint research collaboration agreement, which covers activities from candidate drug generation up until IND-enabling studies, each company will be responsible for its own costs. The parties may continue further development of the resulting bispecific molecule und ....

Peter Benson , Malin Carlsson , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Macrogenics Inc , Research Collaboration , Nasdaq Stockholm , Alligator Bioscience , Aptevo Therapeutics , Shanghai Henlius Biotech , Macrogenics Enter , பீட்டர் பென்சன் , மாலின் கார்ல்சன் , ஆராய்ச்சி இணைந்து , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , முதலை உயிர் அறிவியல் ,